Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 12

1.

Cancer statistics, 2007.

Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ.

CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66.

PMID:
17237035
3.

Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology.

Böhm M, Luger TA, Tobin DJ, García-Borrón JC.

J Invest Dermatol. 2006 Sep;126(9):1966-75. Review.

4.

Melanoma therapy via peptide-targeted {alpha}-radiation.

Miao Y, Hylarides M, Fisher DR, Shelton T, Moore H, Wester DW, Fritzberg AR, Winkelmann CT, Hoffman T, Quinn TP.

Clin Cancer Res. 2005 Aug 1;11(15):5616-21.

5.

Radiolabeled peptides in oncology: role in diagnosis and treatment.

Weiner RE, Thakur ML.

BioDrugs. 2005;19(3):145-63. Review.

PMID:
15984900
6.

Imaging of melanoma using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a cyclized peptide analogue of alpha-MSH.

McQuade P, Miao Y, Yoo J, Quinn TP, Welch MJ, Lewis JS.

J Med Chem. 2005 Apr 21;48(8):2985-92.

PMID:
15828837
7.

Evaluation of the human melanoma targeting properties of radiolabeled alpha-melanocyte stimulating hormone peptide analogues.

Miao Y, Whitener D, Feng W, Owen NK, Chen J, Quinn TP.

Bioconjug Chem. 2003 Nov-Dec;14(6):1177-84.

PMID:
14624632
8.

Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties.

Chen J, Cheng Z, Owen NK, Hoffman TJ, Miao Y, Jurisson SS, Quinn TP.

J Nucl Med. 2001 Dec;42(12):1847-55.

10.

The neuropeptide alpha-MSH in HIV infection and other disorders in humans.

Catania A, Airaghi L, Garofalo L, Cutuli M, Lipton JM.

Ann N Y Acad Sci. 1998 May 1;840:848-56. Review.

PMID:
9629310
11.
12.

Characterization of receptors for alpha-melanocyte-stimulating hormone on human melanoma cells.

Siegrist W, Solca F, Stutz S, Giuffrè L, Carrel S, Girard J, Eberle AN.

Cancer Res. 1989 Nov 15;49(22):6352-8.

Supplemental Content

Support Center